You are here: Home » International » News » Markets
Business Standard

Global Markets: Stocks fall on long-short battle, European vaccine row

Wall Street has been gripped by a coordinated assault by small traders organising over online forums

Global Markets | US markets | Hedge funds

Reuters  |  LONDON 

markets, stock market, sensex, correction, nifty, shares, growth, profit, economy, gain
Representational image

European stocks and U.S. stock futures fell on Friday and the safe-haven dollar looked set for a weekly gain as a Wall Street battle between and retail investors and a row in Europe over COVID-19 vaccine supply cooled risk appetite.

Wall Street has been gripped by a coordinated assault by small traders organising over online forums, such as Reddit, to force to reverse short positions - or bets that stocks would fall - on companies such as GameStop and AMC Entertainment.

The attack comes after central bank and government stimulus have propelled stock to record highs, encouraging buying by retail investors.

"The GameStop saga will end, leaving a sour taste in policymakers' mouths," said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.

"The story could be a trigger for action that could bring the government and the central bank to revise their ultra-loose policies that throw liquidity in the middle, and not towards a reasonable target."

Brokers cut off borrowing facilities and restricted trading in some of the hottest names overnight, driving down their prices.

The boss of popular online broker Robinhood said the curbs were deployed to protect the brokerage and its customers but that some restrictions will be lifted on Friday.

S&P 500 futures fell 1.5% and Nasdaq 100 futures fell 1.8%, more than reversing gains made on Thursday as the earnings season got off to a strong start.

Britain's FTSE 100 index fell 1.7% and was set to record its worst week since October. European stocks fell 1.5%.


COVID-19 vaccine production delays have snowballed into a spat between Britain, the European Union and drugmakers over how best to direct limited supplies.

Europe's fight to secure vaccines intensified on Thursday when the EU warned drug companies that it would use all legal means or even block exports unless they agreed to deliver shots as promised.

Britain's former vaccine chief Kate Bingham said on Friday she did not believe the EU would block exports.

New variants of the novel coronavirus have also prolonged lockdowns and delayed expectations of an economic rebound.

"The pandemic continues to cast a dark shadow and the timing of any recovery, economic or social, remains unclear," said Richard Hunter, head of at Interactive Investor.


Click here for an interactive chart on the vaccine race


The U.S. dollar rose to a seven-week high against the yen, and gained 0.2% against an index of currencies, bringing its weekly rise to 0.6%. The euro fell 0.12% and the pound dropped 0.3%.

German 10-year government bond yields ticked up one basis point.

World stocks fell 0.5% towards three-week lows set in the previous session.

MSCI's broadest index of Asia-Pacific shares outside Japan fell 1.1% and is on course for a weekly loss of 4.4%. Japan's Nikkei fell 1.9%, recording its first weekly loss of the year.

Meanwhile, the People's Bank of China (PBOC) injected 100 billion yuan into the financial system on Friday, following a week of reducing liquidity, which had sparked concerns the central bank was in fact tightening monetary policy.

Still, the extra money did little to loosen short-term money markets, where rates rose for a fifth straight day and benchmark overnight repo rates surged to their highest in nearly six years.

Oil prices were steady, sticking to ranges seen in the last three weeks, with stalled vaccine rollouts capping upward momentum.

Brent crude futures were up 0.1% at $55.58 a barrel and U.S. crude futures slipped 0.27% to $52.20 a barrel.


(Additional reporting by Tom Westbrook in Singapore and Alwyn Scott in New York; Editing by Richard Pullin, Ana Nicolaci da Costa, William Maclean)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, January 29 2021. 15:53 IST